CYTOKINETICS, INCORPORATED Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
CYTOKINETICS, INCORPORATED (CYTK) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$404.79 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$198.76M.
- CYTOKINETICS, INCORPORATED net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$206.03M.
- CYTOKINETICS, INCORPORATED net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$183.03M.
- CYTOKINETICS, INCORPORATED net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$306.18M.
- CYTOKINETICS, INCORPORATED net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$784.96M.
- CYTOKINETICS, INCORPORATED net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$589.53M.
- CYTOKINETICS, INCORPORATED net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$526.24M.
- CYTOKINETICS, INCORPORATED net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$388.95M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 167 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 170 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 173 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 176 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 179 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 182 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 185 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 188 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 191 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$198.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$404.79M 10-Q · filed 2026-08-06 | -$587.82M derived: sum of 3 quarters · filed 2026-08-06 | -$894.00M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||
| 2026-03-31 | -$206.03M 10-Q · filed 2026-05-05 | -$389.06M derived: sum of 2 quarters · filed 2026-05-05 | -$695.24M derived: sum of 3 quarters · filed 2026-05-05 | -$829.61M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||
| 2025-12-31 | -$183.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$489.21M derived: sum of 2 quarters · filed 2026-02-26 | -$623.58M derived: sum of 3 quarters · filed 2026-08-06 | -$784.96M 10-K · filed 2026-02-26 | |||||||||
| 2025-09-30 | -$306.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$440.55M derived: sum of 2 quarters · filed 2026-08-06 | -$601.92M 10-Q · filed 2025-11-05 | -$751.94M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||
| 2025-06-30 | -$134.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$295.75M 10-Q · filed 2026-08-06 | -$445.77M derived: sum of 3 quarters · filed 2026-08-06 | -$606.31M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||
| 2025-03-31 | -$161.38M 10-Q · filed 2026-05-05 | -$311.40M derived: sum of 2 quarters · filed 2026-05-05 | -$471.94M derived: sum of 3 quarters · filed 2026-05-05 | -$615.26M derived: sum of 4 quarters · filed 2026-05-05 | |||||||||
| 2024-12-31 | -$150.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$310.56M derived: sum of 2 quarters · filed 2026-02-26 | -$453.88M derived: sum of 3 quarters · filed 2026-02-26 | -$589.53M 10-K · filed 2026-02-26 | |||||||||
| 2024-09-30 | -$160.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$303.86M derived: sum of 2 quarters · filed 2025-11-05 | -$439.51M 10-Q · filed 2025-11-05 | -$576.40M derived: sum of 4 quarters · filed 2026-02-26 | |||||||||
| 2024-06-30 | -$143.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$278.96M 10-Q · filed 2025-08-07 | -$415.86M derived: sum of 3 quarters · filed 2026-02-26 | -$545.28M derived: sum of 4 quarters · filed 2026-02-26 | |||||||||
| 2024-03-31 | -$135.64M 10-Q · filed 2025-05-06 | -$272.54M derived: sum of 2 quarters · filed 2026-02-26 | -$401.96M derived: sum of 3 quarters · filed 2026-02-26 | -$530.60M derived: sum of 4 quarters · filed 2026-02-26 | |||||||||
| 2023-12-31 | -$136.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$266.32M derived: sum of 2 quarters · filed 2026-02-26 | -$394.95M derived: sum of 3 quarters · filed 2026-02-26 | -$526.24M 10-K · filed 2026-02-26 | |||||||||
| 2023-09-30 | -$129.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$258.06M derived: sum of 2 quarters · filed 2024-11-07 | -$389.35M 10-Q · filed 2024-11-07 | -$526.73M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||
| 2023-06-30 | -$128.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$259.93M 10-Q · filed 2024-08-09 | -$397.31M derived: sum of 3 quarters · filed 2025-02-27 | -$539.62M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||
| 2023-03-31 | -$131.29M 10-Q · filed 2024-05-10 | -$268.67M derived: sum of 2 quarters · filed 2025-02-27 | -$410.98M derived: sum of 3 quarters · filed 2025-02-27 | -$430.80M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||
| 2022-12-31 | -$137.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$279.69M derived: sum of 2 quarters · filed 2025-02-27 | -$299.51M derived: sum of 3 quarters · filed 2025-02-27 | -$388.95M 10-K · filed 2025-02-27 | |||||||||
| 2022-09-30 | -$142.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$162.13M derived: sum of 2 quarters · filed 2023-11-03 | -$251.57M 10-Q · filed 2023-11-03 | -$282.14M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||
| 2022-06-30 | -$19.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$109.27M 10-Q · filed 2023-08-03 | -$139.84M derived: sum of 3 quarters · filed 2024-02-28 | -$215.92M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||
| 2022-03-31 | -$89.44M 10-Q · filed 2023-05-05 | -$120.02M derived: sum of 2 quarters · filed 2024-02-28 | -$196.10M derived: sum of 3 quarters · filed 2024-02-28 | -$257.65M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||
| 2021-12-31 | -$30.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$106.66M derived: sum of 2 quarters · filed 2024-02-28 | -$168.21M derived: sum of 3 quarters · filed 2024-02-28 | -$215.31M 10-K · filed 2024-02-28 | |||||||||
| 2021-09-30 | -$76.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$137.64M derived: sum of 2 quarters · filed 2022-11-04 | -$184.74M 10-Q · filed 2022-11-04 | -$228.67M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||
| 2021-06-30 | -$61.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$108.66M 10-Q · filed 2022-08-05 | -$152.59M derived: sum of 3 quarters · filed 2023-03-01 | -$155.76M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||
| 2021-03-31 | -$47.10M 10-Q · filed 2022-05-06 | -$91.03M derived: sum of 2 quarters · filed 2023-03-01 | -$94.21M derived: sum of 3 quarters · filed 2023-03-01 | -$134.99M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||
| 2020-12-31 | -$43.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$47.10M derived: sum of 2 quarters · filed 2023-03-01 | -$87.89M derived: sum of 3 quarters · filed 2023-03-01 | -$127.29M 10-K · filed 2023-03-01 | |||||||||
| 2020-09-30 | -$3.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$43.95M derived: sum of 2 quarters · filed 2021-11-05 | -$83.36M 10-Q · filed 2021-11-05 | -$114.00M derived: sum of 4 quarters · filed 2022-02-25 | |||||||||
| 2020-06-30 | -$40.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$80.19M 10-Q · filed 2021-08-06 | -$110.83M derived: sum of 3 quarters · filed 2022-02-25 | -$140.40M derived: sum of 4 quarters · filed 2022-02-25 | |||||||||
| 2020-03-31 | -$39.41M 10-Q · filed 2021-05-07 | -$70.05M derived: sum of 2 quarters · filed 2022-02-25 | -$99.62M derived: sum of 3 quarters · filed 2022-02-25 | -$131.73M derived: sum of 4 quarters · filed 2022-02-25 | |||||||||
| 2019-12-31 | -$30.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$60.21M derived: sum of 2 quarters · filed 2022-02-25 | -$92.33M derived: sum of 3 quarters · filed 2022-02-25 | -$121.69M 10-K · filed 2022-02-25 | |||||||||
| 2019-09-30 | -$29.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$61.69M derived: sum of 2 quarters · filed 2020-11-06 | -$91.05M 10-Q · filed 2020-11-06 | -$117.52M derived: sum of 4 quarters · filed 2021-02-26 | |||||||||
| 2019-06-30 | -$32.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$61.48M 10-Q · filed 2020-08-07 | -$87.95M derived: sum of 3 quarters · filed 2021-02-26 | -$109.96M derived: sum of 4 quarters · filed 2021-02-26 | |||||||||
| 2019-03-31 | -$29.37M 10-Q · filed 2020-05-08 | -$55.83M derived: sum of 2 quarters · filed 2021-02-26 | -$77.85M derived: sum of 3 quarters · filed 2021-02-26 | -$105.37M derived: sum of 4 quarters · filed 2021-02-26 | |||||||||
| 2018-12-31 | -$26.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$48.48M derived: sum of 2 quarters · filed 2021-02-26 | -$76.01M derived: sum of 3 quarters · filed 2021-02-26 | -$106.29M 10-K · filed 2021-02-26 | |||||||||
| 2018-09-30 | -$22.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$49.54M derived: sum of 2 quarters · filed 2019-11-01 | -$79.82M 10-Q · filed 2019-11-01 | -$120.31M derived: sum of 4 quarters · filed 2019-11-01 | |||||||||
| 2018-06-30 | -$27.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$57.80M 10-Q · filed 2019-08-09 | -$98.29M derived: sum of 3 quarters · filed 2019-08-09 | -$130.65M derived: sum of 4 quarters · filed 2019-08-09 | |||||||||
| 2018-03-31 | -$30.28M 10-Q · filed 2019-05-09 | -$70.77M derived: sum of 2 quarters · filed 2019-05-09 | -$103.12M derived: sum of 3 quarters · filed 2019-05-09 | ||||||||||
| 2017-12-31 | -$40.48M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$72.84M derived: sum of 2 quarters · filed 2019-03-07 | -$127.79M 10-K · filed 2019-03-07 | ||||||||||
| 2017-09-30 | -$32.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$87.31M 10-Q · filed 2018-11-09 | |||||||||||
| 2017-06-30 | -$54.95M 10-Q · filed 2018-08-07 | ||||||||||||
| 2014-06-30 | -$8.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$17.12M 10-Q · filed 2014-08-07 | |||||||||||
| 2014-03-31 | -$8.74M 10-Q · filed 2014-05-07 | ||||||||||||
| 2013-12-31 | -$33.72M 10-K · filed 2014-03-07 | ||||||||||||
| 2013-06-30 | -$15.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$27.66M 10-Q · filed 2014-08-07 | -$39.12M derived: sum of 3 quarters · filed 2014-08-07 | -$49.16M derived: sum of 4 quarters · filed 2014-08-07 | -$476.54M 10-Q · filed 2013-08-07 | ||||||||
| 2013-03-31 | -$12.62M 10-Q · filed 2014-05-07 | -$24.07M derived: sum of 2 quarters · filed 2014-05-07 | -$34.12M derived: sum of 3 quarters · filed 2014-05-07 | -$43.06M derived: sum of 4 quarters · filed 2014-05-07 | -$461.50M 10-Q · filed 2013-05-08 | ||||||||
| 2012-12-31 | -$11.46M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$21.50M derived: sum of 2 quarters · filed 2014-03-07 | -$30.44M derived: sum of 3 quarters · filed 2014-03-07 | -$40.37M 10-K · filed 2014-03-07 | -$448.88M 10-K · filed 2013-03-15 | ||||||||
| 2012-09-30 | -$10.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$18.99M derived: sum of 2 quarters · filed 2013-08-07 | -$28.91M 10-Q · filed 2012-11-07 | -$40.79M derived: sum of 4 quarters · filed 2014-03-07 | -$437.42M 10-Q · filed 2012-11-07 | ||||||||
| 2012-06-30 | -$8.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$18.87M 10-Q · filed 2013-08-07 | -$30.75M derived: sum of 3 quarters · filed 2014-03-07 | -$41.39M derived: sum of 4 quarters · filed 2014-03-07 | -$427.38M 10-Q · filed 2012-08-06 | ||||||||
| 2012-03-31 | -$9.93M 10-Q · filed 2013-05-08 | -$21.81M derived: sum of 2 quarters · filed 2014-03-07 | -$32.44M derived: sum of 3 quarters · filed 2014-03-07 | -$46.08M derived: sum of 4 quarters · filed 2014-03-07 | -$418.44M 10-Q · filed 2012-05-04 | ||||||||
| 2011-12-31 | -$11.88M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$22.52M derived: sum of 2 quarters · filed 2014-03-07 | -$36.15M derived: sum of 3 quarters · filed 2014-03-07 | -$47.86M 10-K · filed 2014-03-07 | -$408.51M 10-K · filed 2012-03-13 | ||||||||
| 2011-09-30 | -$10.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$24.27M derived: sum of 2 quarters · filed 2012-11-07 | -$35.98M 10-Q · filed 2012-11-07 | -$47.59M derived: sum of 4 quarters · filed 2013-03-15 | -$396.63M 10-Q · filed 2011-11-04 | ||||||||
| 2011-06-30 | -$13.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | -$25.34M 10-Q · filed 2012-08-06 | -$36.96M derived: sum of 3 quarters · filed 2013-03-15 | -$49.30M derived: sum of 4 quarters · filed 2013-03-15 | -$385.99M 10-Q · filed 2011-08-04 | ||||||||
| 2011-03-31 | -$11.71M 10-Q · filed 2012-05-04 | -$23.32M derived: sum of 2 quarters · filed 2013-03-15 | -$35.67M derived: sum of 3 quarters · filed 2013-03-15 | ||||||||||
| 2010-12-31 | -$11.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$23.95M derived: sum of 2 quarters · filed 2013-03-15 | -$49.29M 10-K · filed 2013-03-15 | ||||||||||
| 2010-09-30 | -$12.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$37.67M 10-Q · filed 2011-11-04 | |||||||||||
| 2010-06-30 | -$25.33M 10-Q · filed 2011-08-04 | ||||||||||||
| 2009-12-31 | $24.54M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |